Avidity Biosciences的Del-Zota在Explore44®和Explore44-Ole™ 1/2期试验中证实在关键功能终点实现了Dmd44患者疾病进展的逆转
Avidity Biosciences的Del-Zota在Explore44®和Explore44-Ole™ 1/2期试验中证实在关键功能终点实现了Dmd44患者疾病进展的逆转
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.